BlackRock’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.74B | Buy |
|
|||||
|
2025
Q1 | $10.6B | Sell |
|
|||||
|
2024
Q4 | $8.79B | Buy |
|
|||||
|
2024
Q3 | $10.1B | Buy |
|
|||||
|
2024
Q2 | $9.99B | Sell |
|
|||||
|
2024
Q1 | $9.18B | Buy |
|
|||||
|
2023
Q4 | $8.9B | Sell |
|
|||||
|
2023
Q3 | $7.85B | Sell |
|
|||||
|
2023
Q2 | $8.03B | Sell |
|
|||||
|
2023
Q1 | $7.53B | Sell |
|
|||||
|
2022
Q4 | $7B | Sell |
|
|||||
|
2022
Q3 | $7.31B | Buy |
|
|||||
|
2022
Q2 | $7.08B | Buy |
|
|||||
|
2022
Q1 | $6.24B | Sell |
|
|||||
|
2021
Q4 | $5.26B | Buy |
|
|||||
|
2021
Q3 | $4.27B | Buy |
|
|||||
|
2021
Q2 | $4.71B | Sell |
|
|||||
|
2021
Q1 | $5.21B | Sell |
|
|||||
|
2020
Q4 | $5.74B | Sell |
|
|||||
|
2020
Q3 | $6.85B | Sell |
|
|||||
|
2020
Q2 | $7.41B | Buy |
|
|||||
|
2020
Q1 | $5.31B | Buy |
|
|||||
|
2019
Q4 | $4.62B | Buy |
|
|||||
|
2019
Q3 | $3.57B | Buy |
|
|||||
|
2019
Q2 | $3.8B | Buy |
|
|||||
|
2019
Q1 | $3.71B | Buy |
|
|||||
|
2018
Q4 | $3.25B | Sell |
|
|||||
|
2018
Q3 | $3.84B | Buy |
|
|||||
|
2018
Q2 | $3.28B | Sell |
|
|||||
|
2018
Q1 | $3.24B | Buy |
|
|||||
|
2017
Q4 | $2.91B | Sell |
|
|||||
|
2017
Q3 | $3B | Buy |
|
|||||
|
2017
Q2 | $2.5B | Buy |
|
|||||
|
2017
Q1 | $2.1B | Buy |
|
|||||
|
2016
Q4 | $50.6M | Sell |
|
|||||
|
2016
Q3 | $65.2M | Buy |
|
|||||
|
2016
Q2 | $63.6M | Buy |
|
|||||
|
2016
Q1 | $53.9M | Sell |
|
|||||
|
2015
Q4 | $89.7M | Buy |
|
|||||
|
2015
Q3 | $71.8M | Sell |
|
|||||
|
2015
Q2 | $93.7M | Sell |
|
|||||
|
2015
Q1 | $113M | Buy |
|
|||||
|
2014
Q4 | $104M | Buy |
|
|||||
|
2014
Q3 | $75.8M | Buy |
|
|||||
|
2014
Q2 | $51.9M | Sell |
|
|||||
|
2014
Q1 | $43.8M | Sell |
|
|||||
|
2013
Q4 | $51.5M | Buy |
|
|||||
|
2013
Q3 | $42.6M | Buy |
|
|||||
|
2013
Q2 | $10.5M | Buy |
|